Long-Term Efficacy and Safety of Mavacamten in Symptomatic Patients with Obstructive Hypertrophic Cardiomyopathy

Sharlene M. Day; James E. Udelson; Robert O. Bonow

doi:10.1001/jamacardio.2023.3357

Long-Term Efficacy and Safety of Mavacamten in Symptomatic Patients with Obstructive Hypertrophic Cardiomyopathy

Sharlene M. Day^*, James E. Udelson, Robert O. Bonow

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	978
Number of pages	1
Journal	JAMA cardiology
Volume	8
Issue number	10
DOIs	https://doi.org/10.1001/jamacardio.2023.3357
State	Published - Oct 11 2023

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jamacardio.2023.3357

Cite this

@article{3eedb144f88842aea1577ec90420155a,

title = "Long-Term Efficacy and Safety of Mavacamten in Symptomatic Patients with Obstructive Hypertrophic Cardiomyopathy",

author = "Day, {Sharlene M.} and Udelson, {James E.} and Bonow, {Robert O.}",

year = "2023",

month = oct,

day = "11",

doi = "10.1001/jamacardio.2023.3357",

language = "English (US)",

volume = "8",

pages = "978",

journal = "JAMA cardiology",

issn = "2380-6583",

publisher = "American Medical Association",

number = "10",

}

TY - JOUR

T1 - Long-Term Efficacy and Safety of Mavacamten in Symptomatic Patients with Obstructive Hypertrophic Cardiomyopathy

AU - Day, Sharlene M.

AU - Udelson, James E.

AU - Bonow, Robert O.

PY - 2023/10/11

Y1 - 2023/10/11

UR - http://www.scopus.com/inward/record.url?scp=85175241811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85175241811&partnerID=8YFLogxK

U2 - 10.1001/jamacardio.2023.3357

DO - 10.1001/jamacardio.2023.3357

M3 - Comment/debate

C2 - 37639276

AN - SCOPUS:85175241811

SN - 2380-6583

VL - 8

SP - 978

JO - JAMA cardiology

JF - JAMA cardiology

IS - 10

ER -

Long-Term Efficacy and Safety of Mavacamten in Symptomatic Patients with Obstructive Hypertrophic Cardiomyopathy

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this